FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2898855568> ?p ?o ?g. }

• W2898855568 endingPage "397" @default.
• W2898855568 startingPage "388" @default.
• W2898855568 abstract "Protease inhibitors (PIs) are of central importance in the treatment of patients with chronic hepatitis C virus (HCV) infection. HCV NS3 protease (NS3P) position 80 displays polymorphisms associated with resistance to the PI simeprevir for HCV genotype 1a. We investigated the effects of position-80-substitutions on fitness and PI-resistance for HCV genotypes 1-6, and analyzed evolutionary mechanisms underlying viral escape mediated by pre-existing Q80K.The fitness of infectious NS3P recombinants of HCV genotypes 1-6, with engineered position-80-substitutions, was studied by comparison of viral spread kinetics in Huh-7.5 cells in culture. Median effective concentration (EC50) and fold resistance for PIs simeprevir, asunaprevir, paritaprevir, grazoprevir, glecaprevir and voxilaprevir were determined in short-term treatment assays. Viral escape was studied by long-term treatment of genotype 1a recombinants with simeprevir, grazoprevir, glecaprevir and voxilaprevir and of genotype 3a recombinants with glecaprevir and voxilaprevir, next generation sequencing, NS3P substitution linkage and haplotype analysis.Among tested PIs, only glecaprevir and voxilaprevir showed pan-genotypic activity against the original genotype 1-6 culture viruses. Variants with position-80-substitutions were all viable, but fitness depended on the specific substitution and the HCV isolate. Q80K conferred resistance to simeprevir across genotypes but had only minor effects on the activity of the remaining PIs. For genotype 1a, pre-existing Q80K mediated accelerated escape from simeprevir, grazoprevir and to a lesser extent glecaprevir, but not voxilaprevir. For genotype 3a, Q80K mediated accelerated escape from glecaprevir and voxilaprevir. Escape was mediated by rapid and genotype-, PI- and PI-concentration-dependent co-selection of clinically relevant resistance associated substitutions.Position-80-substitutions had relatively low fitness cost and the potential to promote HCV escape from clinically relevant PIs in vitro, despite having a minor impact on results in classical short-term resistance assays.Among all clinically relevant hepatitis C virus protease inhibitors, voxilaprevir and glecaprevir showed the highest and most uniform activity against cell culture infectious hepatitis C virus with genotype 1-6 proteases. Naturally occurring amino acid changes at protease position 80 had low fitness cost and influenced sensitivity to simeprevir, but not to other protease inhibitors in short-term treatment assays. Nevertheless, the pre-existing change Q80K had the potential to promote viral escape from protease inhibitors during long-term treatment by rapid co-selection of additional resistance changes, detected by next generation sequencing." @default.
• W2898855568 created "2018-11-09" @default.
• W2898855568 creator A5009268970 @default.
• W2898855568 creator A5023059992 @default.
• W2898855568 creator A5031709092 @default.
• W2898855568 creator A5031824210 @default.
• W2898855568 creator A5038234181 @default.
• W2898855568 creator A5047201179 @default.
• W2898855568 creator A5048146081 @default.
• W2898855568 creator A5051400918 @default.
• W2898855568 creator A5065447488 @default.
• W2898855568 creator A5066391487 @default.
• W2898855568 creator A5073835639 @default.
• W2898855568 creator A5088266410 @default.
• W2898855568 date "2019-03-01" @default.
• W2898855568 modified "2023-10-05" @default.
• W2898855568 title "HCV genotype 1-6 NS3 residue 80 substitutions impact protease inhibitor activity and promote viral escape" @default.
• W2898855568 cites W1810718519 @default.
• W2898855568 cites W1967785127 @default.
• W2898855568 cites W1980805512 @default.
• W2898855568 cites W1989027571 @default.
• W2898855568 cites W1990127122 @default.
• W2898855568 cites W2001129358 @default.
• W2898855568 cites W2011893864 @default.
• W2898855568 cites W2023926449 @default.
• W2898855568 cites W2029071724 @default.
• W2898855568 cites W2045139944 @default.
• W2898855568 cites W2060812911 @default.
• W2898855568 cites W2063966947 @default.
• W2898855568 cites W2112024536 @default.
• W2898855568 cites W2125958583 @default.
• W2898855568 cites W2130921346 @default.
• W2898855568 cites W2132945338 @default.
• W2898855568 cites W2133104574 @default.
• W2898855568 cites W2142385013 @default.
• W2898855568 cites W2147126871 @default.
• W2898855568 cites W2149722964 @default.
• W2898855568 cites W2159094299 @default.
• W2898855568 cites W2164466220 @default.
• W2898855568 cites W2185218296 @default.
• W2898855568 cites W2207184126 @default.
• W2898855568 cites W2295408863 @default.
• W2898855568 cites W2317154379 @default.
• W2898855568 cites W2318156787 @default.
• W2898855568 cites W2409760813 @default.
• W2898855568 cites W2472129033 @default.
• W2898855568 cites W2490691249 @default.
• W2898855568 cites W2502822043 @default.
• W2898855568 cites W2520597593 @default.
• W2898855568 cites W2578013986 @default.
• W2898855568 cites W2586420967 @default.
• W2898855568 cites W2597648476 @default.
• W2898855568 cites W2613151323 @default.
• W2898855568 cites W2667085915 @default.
• W2898855568 cites W2765116944 @default.
• W2898855568 cites W2765212316 @default.
• W2898855568 cites W2769010101 @default.
• W2898855568 cites W2769985632 @default.
• W2898855568 cites W2786448332 @default.
• W2898855568 cites W2788216918 @default.
• W2898855568 cites W2794341756 @default.
• W2898855568 cites W2799470492 @default.
• W2898855568 cites W2883834853 @default.
• W2898855568 cites W2886511433 @default.
• W2898855568 doi "https://doi.org/10.1016/j.jhep.2018.10.031" @default.
• W2898855568 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30395912" @default.
• W2898855568 hasPublicationYear "2019" @default.
• W2898855568 type Work @default.
• W2898855568 sameAs 2898855568 @default.
• W2898855568 citedByCount "33" @default.
• W2898855568 countsByYear W28988555682019 @default.
• W2898855568 countsByYear W28988555682020 @default.
• W2898855568 countsByYear W28988555682021 @default.
• W2898855568 countsByYear W28988555682022 @default.
• W2898855568 countsByYear W28988555682023 @default.
• W2898855568 crossrefType "journal-article" @default.
• W2898855568 hasAuthorship W2898855568A5009268970 @default.
• W2898855568 hasAuthorship W2898855568A5023059992 @default.
• W2898855568 hasAuthorship W2898855568A5031709092 @default.
• W2898855568 hasAuthorship W2898855568A5031824210 @default.
• W2898855568 hasAuthorship W2898855568A5038234181 @default.
• W2898855568 hasAuthorship W2898855568A5047201179 @default.
• W2898855568 hasAuthorship W2898855568A5048146081 @default.
• W2898855568 hasAuthorship W2898855568A5051400918 @default.
• W2898855568 hasAuthorship W2898855568A5065447488 @default.
• W2898855568 hasAuthorship W2898855568A5066391487 @default.
• W2898855568 hasAuthorship W2898855568A5073835639 @default.
• W2898855568 hasAuthorship W2898855568A5088266410 @default.
• W2898855568 hasConcept C104317684 @default.
• W2898855568 hasConcept C132379496 @default.
• W2898855568 hasConcept C135763542 @default.
• W2898855568 hasConcept C159047783 @default.
• W2898855568 hasConcept C2522874641 @default.
• W2898855568 hasConcept C2776408679 @default.
• W2898855568 hasConcept C2778986448 @default.
• W2898855568 hasConcept C2780040827 @default.
• W2898855568 hasConcept C54355233 @default.
• W2898855568 hasConcept C86803240 @default.

• next